Interleukin 35 and hepatocyte growth factor; as a Novel Combined Immune Gene Therapy for Multiple Sclerosis Disease

An autoimmune demyelination disease of the Central Nervous System, Multiple Sclerosis, is a chronic inflammation which mostly involves young adults. Suffering people face functional loss with a severe pain. Most current MS treatments are focused on the immune response suppression. Approved drugs suppress the inflammatory process, but factually, there is no definite cure for Multiple Sclerosis. Recently developed knowledge has demonstrated that gene and cell therapy as a hopeful approach in tissue regeneration.

Source: Medical Hypotheses - September 22, 2017 Category: Biomedical Science Authors: Samira Moghadam, Maryam Erfanmanesh, Abdolreza Esmaeilzadeh Source Type: research